Even so, the potential number of people eligible is big enough that, even if the vast majority never fill a prescription, the weight-loss drugs could quickly become among the most common drugs in America, and the most expensive for insurers to cover
advanced anastomosis healing (A), macoscopicallly preserved mucosa (B), day 3 (HE (upper), Mallory (middle) staining, 40): smaller gap (C), less inflammatory cells, collagen in mucosa and submucosa and granulation tissue (green fibers, Mallory staining) (D)
The label read, simply: Retatrutide
For many patients, cost has historically been one of the biggest barriers to treatment, with retail cash prices for brand-name Wegovy and Zepbound previously exceeding $1,000 per month